» Articles » PMID: 30774654

Serrated Lesions of the Colon-Rectum: A Focus on New Diagnostic Tools and Current Management

Overview
Publisher Wiley
Specialty Gastroenterology
Date 2019 Feb 19
PMID 30774654
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Prompt diagnosis and correct management of the so called "serrated lesions" (SLs) of the colon-rectum are generally considered of crucial importance in the past years, mainly due to their histological heterogeneity and peculiar clinical and molecular patterns; sometimes, they are missed at conventional endoscopy and are possibly implicated in the genesis of interval cancers. The aim of this review is to focus on the diagnostic challenges of serrated lesions, underlying the role of both conventional endoscopy and novel technologies. We will show how an accurate and precise diagnosis should immediately prompt the most appropriate therapy other than defining a proper follow-up program. It will be emphasized how novel endoscopic techniques may provide better visualization of mucosal microsurface structures other than enhancing the microvascular architecture, in order to better define and characterize specific patterns of mucosal lesions of the gastrointestinal tract. Standard therapy of SLs of the colon-rectum is still very debated, also due to the relatively lack of studies focusing on treatment issues. The high risk of incomplete resection, together with the high rate of postcolonoscopy interval cancers, suggests the need of an extra care when facing this kind of lesions. Given this background, we will outline useful technical tips and tricks in the resection of SLs, taking aspects such as the size and location of the lesions, as well as novel available techniques and technologies, other than future perspectives, including confocal laser endomicroscopy into consideration. Follow-up of SLs is another hot topic, also considering that their clinical impact has been misunderstood for a long time. The incidence of the so called interval colorectal cancer underlines how some weaknesses exist in current screening and follow-up programs. Considering the lack of wide consensus for the management of some SLs, we will try to summarize and clarify the best strategies for their optimal management.

Citing Articles

Risk Factors in Serrated Pathway Lesions: N-Glycosylation Profile as a Potential Biomarker of Progression to Malignancy.

Fernandes-Mendes H, M Azevedo C, Garrido M, Lemos C, Pedroto I, Pinho S GE Port J Gastroenterol. 2024; 31(5):338-350.

PMID: 39360170 PMC: 11444659. DOI: 10.1159/000535920.


Current progress on the endoscopic features of colorectal sessile serrated lesions.

Wang R, Wei L, Jiang B World J Clin Oncol. 2023; 14(4):171-178.

PMID: 37124132 PMC: 10134204. DOI: 10.5306/wjco.v14.i4.171.


MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.

Raduta D, Dinca O, Micu G, Nichita L, Cioplea M, Busca R Rom J Morphol Embryol. 2022; 62(4):971-979.

PMID: 35673816 PMC: 9289700. DOI: 10.47162/RJME.62.4.09.


Endorectal Ultrasonography and Pelvic Magnetic Resonance Imaging Show Similar Diagnostic Accuracy in Local Staging of Rectal Cancer: An Update Systematic Review and Meta-Analysis.

Luglio G, Pagano G, Tropeano F, Spina E, Maione R, Chini A Diagnostics (Basel). 2022; 12(1).

PMID: 35054171 PMC: 8775222. DOI: 10.3390/diagnostics12010005.


Serrated lesions of the colon and rectum: Emergent epidemiological data and molecular pathways.

Sacco M, De Palma F, Guadagno E, Giglio M, Peltrini R, Marra E Open Med (Wars). 2020; 15(1):1087-1095.

PMID: 33336065 PMC: 7718641. DOI: 10.1515/med-2020-0226.


References
1.
Toyota M, Ahuja N, Herman J, Baylin S, Issa J . CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999; 96(15):8681-6. PMC: 17576. DOI: 10.1073/pnas.96.15.8681. View

2.
Kudo S, Rubio C, Teixeira C, Kashida H, Kogure E . Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy. 2001; 33(4):367-73. DOI: 10.1055/s-2004-826104. View

3.
Davies H, Bignell G, Cox C, Stephens P, Edkins S, Clegg S . Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892):949-54. DOI: 10.1038/nature00766. View

4.
Hawkins N, Bariol C, Ward R . The serrated neoplasia pathway. Pathology. 2003; 34(6):548-55. View

5.
Park S, Rashid A, Lee J, Kim S, Hamilton S, Wu T . Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol. 2003; 162(3):815-22. PMC: 1868094. DOI: 10.1016/S0002-9440(10)63878-3. View